414 related articles for article (PubMed ID: 28810904)
41. Radiofrequency catheter ablation maintains its efficacy better than antiarrhythmic medication in patients with paroxysmal atrial fibrillation: On-treatment analysis of the randomized controlled MANTRA-PAF trial.
Raatikainen MJ; Hakalahti A; Uusimaa P; Nielsen JC; Johannessen A; Hindricks G; Walfridsson H; Pehrson S; Englund A; Hartikainen J; Kongstad O; Mortensen LS; Hansen PS;
Int J Cardiol; 2015 Nov; 198():108-14. PubMed ID: 26163901
[TBL] [Abstract][Full Text] [Related]
42. Atrial fibrillation management: a prospective survey in ESC member countries: the Euro Heart Survey on Atrial Fibrillation.
Nieuwlaat R; Capucci A; Camm AJ; Olsson SB; Andresen D; Davies DW; Cobbe S; Breithardt G; Le Heuzey JY; Prins MH; Lévy S; Crijns HJ;
Eur Heart J; 2005 Nov; 26(22):2422-34. PubMed ID: 16204266
[TBL] [Abstract][Full Text] [Related]
43. Performance of an expedited rhythm control method for recent onset atrial fibrillation in a community hospital.
White JL; Heller MB; Kahoud RJ; Slade D; Harding JD
Am J Emerg Med; 2015 Jul; 33(7):957-62. PubMed ID: 26001737
[TBL] [Abstract][Full Text] [Related]
44. Treatment of Atrial Fibrillation.
Prystowsky EN; Padanilam BJ; Fogel RI
JAMA; 2015 Jul; 314(3):278-88. PubMed ID: 26197188
[TBL] [Abstract][Full Text] [Related]
45. Emergency Atrial Fibrillation Registry of the Catalan Institute of Health (URGFAICS): analysis by type of atrial fibrillation and revisits within 30 days.
Jacob J; Cabello I; Yuguero O; Alexis Guzmán J; Arranz Betegón M; Abadías MJ; Francés Artigas P; Santos J; Esquerrà A; Mòdol JM
Emergencias; 2019 Abr; 31(2):99-106. PubMed ID: 30963737
[TBL] [Abstract][Full Text] [Related]
46. Rhythm versus rate control in the contemporary management of atrial fibrillation in-hospital.
Allen Lapointe NM; Sun JL; Kaplan S; d'Almada P; Al-Khatib SM
Am J Cardiol; 2008 Apr; 101(8):1134-41. PubMed ID: 18394447
[TBL] [Abstract][Full Text] [Related]
47. Improved outcomes with European Society of Cardiology guideline-adherent antithrombotic treatment in high-risk patients with atrial fibrillation: a report from the EORP-AF General Pilot Registry.
Lip GY; Laroche C; Popescu MI; Rasmussen LH; Vitali-Serdoz L; Dan GA; Kalarus Z; Crijns HJ; Oliveira MM; Tavazzi L; Maggioni AP; Boriani G
Europace; 2015 Dec; 17(12):1777-86. PubMed ID: 26321406
[TBL] [Abstract][Full Text] [Related]
48. Disparities in management of new-onset atrial fibrillation in the emergency department despite adherence to the current guidelines: data from a large metropolitan area.
Buccelletti F; Di Somma S; Galante A; Pugliese F; Alegiani F; Bertazzoni G; Silveri NG; Legramante JM; Franceschi F
Intern Emerg Med; 2011 Apr; 6(2):149-56. PubMed ID: 21318609
[TBL] [Abstract][Full Text] [Related]
49. The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study: approaches to control rate in atrial fibrillation.
Olshansky B; Rosenfeld LE; Warner AL; Solomon AJ; O'Neill G; Sharma A; Platia E; Feld GK; Akiyama T; Brodsky MA; Greene HL;
J Am Coll Cardiol; 2004 Apr; 43(7):1201-8. PubMed ID: 15063430
[TBL] [Abstract][Full Text] [Related]
50. Prognosis and treatment of atrial fibrillation patients by European cardiologists: one year follow-up of the EURObservational Research Programme-Atrial Fibrillation General Registry Pilot Phase (EORP-AF Pilot registry).
Lip GY; Laroche C; Ioachim PM; Rasmussen LH; Vitali-Serdoz L; Petrescu L; Darabantiu D; Crijns HJ; Kirchhof P; Vardas P; Tavazzi L; Maggioni AP; Boriani G
Eur Heart J; 2014 Dec; 35(47):3365-76. PubMed ID: 25176940
[TBL] [Abstract][Full Text] [Related]
51. Systematic review and cost-effectiveness evaluation of 'pill-in-the-pocket' strategy for paroxysmal atrial fibrillation compared to episodic in-hospital treatment or continuous antiarrhythmic drug therapy.
Saborido CM; Hockenhull J; Bagust A; Boland A; Dickson R; Todd D
Health Technol Assess; 2010 Jun; 14(31):iii-iv, 1-75. PubMed ID: 20569652
[TBL] [Abstract][Full Text] [Related]
52. Ibutilide to expedite ED therapy for recent-onset atrial fibrillation flutter.
Mountantonakis SE; Moutzouris DA; Tiu RV; Papaioannou GN; McPherson CA
Am J Emerg Med; 2006 Jul; 24(4):407-12. PubMed ID: 16787796
[TBL] [Abstract][Full Text] [Related]
53. Quality of life after the initial treatment of atrial fibrillation with cryoablation versus drug therapy.
Wazni O; Dandamudi G; Sood N; Hoyt R; Tyler J; Durrani S; Niebauer M; Makati K; Halperin B; Gauri A; Morales G; Shao M; Pouliot E; Kaplon RE; Nissen SE;
Heart Rhythm; 2022 Feb; 19(2):197-205. PubMed ID: 34666139
[TBL] [Abstract][Full Text] [Related]
54. Clinical presentation, management, and outcomes in the Indian Heart Rhythm Society-Atrial Fibrillation (IHRS-AF) registry.
Vora A; Kapoor A; Nair M; Lokhandwala Y; Narsimhan C; Ravikishore AG; Dwivedi SK; Namboodiri N; Hygriv R; Saxena A; Nabar A; Garg S; Bardoloi N; Yadav R; Nambiar A; Pandurangi U; Jhala D; Naik A; Nagmallesh ; Rajagopal S; Selvaraj R; Arora V; Thachil A; Thomas J; Panicker G
Indian Heart J; 2017; 69(1):43-47. PubMed ID: 28228305
[TBL] [Abstract][Full Text] [Related]
55. Antiarrhythmic drug therapy for maintaining sinus rhythm early after pulmonary vein ablation in patients with symptomatic atrial fibrillation.
Sohns C; von Gruben V; Sossalla S; Bergau L; Seegers J; Lüthje L; Vollmann D; Zabel M
Cardiovasc Ther; 2014 Feb; 32(1):7-12. PubMed ID: 24138075
[TBL] [Abstract][Full Text] [Related]
56. Adherence to guideline recommendations for antiarrhythmic drugs in atrial fibrillation.
Allen LaPointe NM; Lokhnygina Y; Sanders GD; Peterson ED; Al-Khatib SM
Am Heart J; 2013 Nov; 166(5):871-8. PubMed ID: 24176443
[TBL] [Abstract][Full Text] [Related]
57. Relations between baseline burden, maximum duration, and relative reduction of atrial fibrillation: Insights from continuous monitoring in rhythm control.
Lin PL; Huang CC; Wu YJ; Su MI; Chiou WR; Liu LY; Liao FC; Lai E; Chen CY; Kuo JY; Lee YH
J Cardiovasc Electrophysiol; 2019 Feb; 30(2):178-182. PubMed ID: 30575199
[TBL] [Abstract][Full Text] [Related]
58. Radiofrequency catheter ablation and antiarrhythmic drug therapy: a prospective, randomized, 4-year follow-up trial: the APAF study.
Pappone C; Vicedomini G; Augello G; Manguso F; Saviano M; Baldi M; Petretta A; Giannelli L; Calovic Z; Guluta V; Tavazzi L; Santinelli V
Circ Arrhythm Electrophysiol; 2011 Dec; 4(6):808-14. PubMed ID: 21946315
[TBL] [Abstract][Full Text] [Related]
59. [Health-related quality of life of patients with atrial fibrillation managed by cardiologists: MOVE study].
Kirch W; Pittrow D; Bosch RF; Kohlhaussen A; Willich SN; Rosin L; Bonnemeier H;
Dtsch Med Wochenschr; 2010 Mar; 135 Suppl 2():S26-32. PubMed ID: 20221975
[TBL] [Abstract][Full Text] [Related]
60. Clinical Outcomes of Rate vs Rhythm Control for Atrial Fibrillation in Older People: A Systematic Review and Meta-Analysis.
Depoorter L; Sels L; Deschodt M; Van Grootven B; Van der Linden L; Tournoy J
Drugs Aging; 2020 Jan; 37(1):19-26. PubMed ID: 31745834
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
